Outcome Measure
Five Facet Mindfulness Questionnaire
What it measures?
- The Five Facet Mindfulness Questionnaire (FFMQ) is one of the most widely used and evaluated measures of mindfulness (Baer et al. 2008, Shallcross et al. 2021).
- The FFMQ assesses five different aspects of mindfulness: observing, describing, acting with awareness, non-judging, and non-reactivity to inner experience.
- Observation entails the ways we use our sensory awareness. It involves how we see, feel, and perceive the internal and external world around us and select the stimuli that require our attention and focus.
- Describing reflects the way we label our experiences and express them in words to ourselves and others.
- Acting with Awareness studies the movements we choose after attending to the information present at the moment.
- Non-judgment/non-judging assesses self-acceptance and empathy for oneself and others.
- Non-reactivity refers to active detachment from negative thoughts and emotions so that we can accept their existence and choose not to react to them.
- Some studies argue that reliability is low for the Full-Scale FFMQ (Aguado et al., 2015, Baer et al., 2008) or that FFMQ measures do not directly reflect a latent variable of mindfulness (Van Dam, 2012) and, therefore, report only subscale scores for each of the five domains of mindfulness.
- The test originates from an exploratory analysis of similar tests such as the Mindfulness Awareness Scales (Brown & Ryan, 2003), Cognitive Affective Mindfulness Scale (Hayes & Feldman, 2004), Kentucky Inventory of Mindfulness Skills (Baer et al., 2004), and Freiburg Mindfulness Inventory (Walach et al., 2006).
Who is it for?
Adults aged 18 years +
Instrument Quality
- The 39-item version of the FFMQ (Baer et al., 2006), has reasonable psychometric properties in students, community members, and meditators (Baer et al., 2006; Baer et al., 2008), though its properties have varied across groups (Baer et al., 2008; Van Dam et al., 2009).
- A factor analysis of the five facets of FFMQ revealed that the hierarchical structure of the factors justify the traits that each element claims to measure (Baer et al., 2006; Baer et al., 2008).
Structure
- 39 items
- Each subscale has 8 questions, except Non-Reactivity which has 7
- Items are rated on a five-point categorical response scale ranging from 1 (never or very rarely true) to 5 (very often or always true).
- Respondents are asked to rate each statement with the number/response that best describes their own opinion of what is generally true for them.
Scoring instructions
- Sum all items together to calculate the Full Scale FFMQ.
- Sum items in each sub-scale to calculate sub-scale scores.
- Total scores range from 39 – 195.
- Subscales range from 5 - 40, except Non-Reactivity which ranges from 5 - 35.
- Note: Reverse score items 12, 16, 22, 5, 8, 13, 18, 23, 28, 34, 38, 3, 10, 14, 17, 25, 30, 35, 39
Subscale | Item number |
---|---|
Observe (FFMQ) |
1,6,11,15,20,26,31,36 |
Nonreactivity (FFMQ) |
4,9,19,21,24,29,33 |
Nonjudging (FFMQ) |
3,10,14,17,25,30,35,39 |
Acting with Awareness (FFMQ) |
5,8,13,18,23,28,34,38 |
Describe (FFMQ) |
2,7,12,16,22,27,32,37 |
Full-scale (FFMQ) |
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39 |
Score Interpretation
What higher scores mean?
- A higher score indicates higher levels of mindfulness and self-awareness in everyday life. The scale also measures the effectiveness of other mindfulness strategies such as MBCT and MBSR (Baer et al., 2006). Scores can range from 39 to 195. The mean score on the Full-Scale FFMQ for a sample with mild-moderate depressive symptoms was 121 (SD = 20.36; Shallcross et al., 2020). Means and SD for subscales in the same population are presented below: Observe M = 25.54, SD = 6.02 Describe M = 27.19, SD = 6.94 Acting with Awareness M = 23.70, SD = 5.81 Non-judgment M = 24.70, SD = 7.11 Non-reactivity M= 19.88, SD = 4.51
How to assess symptom severity & change?
Description | Score Range | |
---|---|---|
Minimum | 8 | |
2 SD below normative mean | 13.36 | |
1 SD below normative mean | 18.58 | |
Normative mean | 24.32 | |
1 SD above normative mean | 29.8 | |
2 SD above normative mean | 35.28 | |
Maximum | 40 |
Description | Score Range | |
---|---|---|
Minimum | 7 | |
2 SD below normative mean | 9.77 | |
1 SD below normative mean | 14.65 | |
Normative mean | 19.53 | |
1 SD above normative mean | 24.41 | |
2 SD above normative mean | 29.29 | |
Maximum | 35 |
Severity ranges
Ranges are drawn from a clinical population, as Full-Scale scores were not calculate in a normative sample. Values are from a sample of 240 participants with mild to moderate levels of self-reported depressive symptoms. The racial/ethnic composition of the sample was: 51% non-Hispanic White; 28% non-Hispanic Black, 8% Hispanic, and 14% Other. The average age was 36 years (SD = 12.2; range: 19–71 years), 75% were female; and 70% had a college degree.
Reliable change and clinically significant improvement
Wampold et al (2001) conducted a meta-analysis of psychotherapy outcome studies and noted that the average improvement was reflected in an effect size (ES) of .80. Because a change of 1 SD corresponds to an ES of 1.0, and .80 is considered to be a large ES, Wise (2004) concludes that a change of 1 SD is a defensible indicator of clinically significant change.
Mean
Sample | Mean | Comments |
---|---|---|
Clinical | 19.88 | Based on a sample of 240 participants with mild to moderate levels of self-reported depressive symptoms. The racial/ethnic composition of the sample was: 51% non-Hispanic White; 28% non-Hispanic Black, 8% Hispanic, and 14% Other. The average age was 36 years (SD = 12.2; range: 19–71 years), 75% were female; and 70% had a college degree. |
Normative | 19.53 | A sample of 293 adults (40% male, 60% female) with an average age of 49.5 (SD = 6.7) who had never meditated before. |
Standard Deviation
Sample | Mean | Comments |
---|---|---|
Clinical | 4.51 | Based on a sample of 240 participants with mild to moderate levels of self-reported depressive symptoms. The racial/ethnic composition of the sample was: 51% non-Hispanic White; 28% non-Hispanic Black, 8% Hispanic, and 14% Other. The average age was 36 years (SD = 12.2; range: 19–71 years), 75% were female; and 70% had a college degree. |
Normative | 4.88 | A sample of 293 adults (40% male, 60% female) with an average age of 49.5 (SD = 6.7) who had never meditated before. |
Reliability
Value | Comments |
---|---|
0.82 | With a sample of 240 racially diverse participants (75% female, 70% university educated) with mild to moderate depressive symptoms, the internal consistency reliability estimate was 0.82 (Shallcross et al., 2020). |
Description | Score Range | |
---|---|---|
Minimum | 8 | |
2 SD below normative mean | 9.19 | |
1 SD below normative mean | 16.52 | |
Normative mean | 23.85 | |
1 SD above normative mean | 31.18 | |
2 SD above normative mean | 38.51 | |
Maximum | 40 |
Severity ranges
Ranges are drawn from a clinical population, as Full-Scale scores were not calculate in a normative sample. Values are from a sample of 240 participants with mild to moderate levels of self-reported depressive symptoms. The racial/ethnic composition of the sample was: 51% non-Hispanic White; 28% non-Hispanic Black, 8% Hispanic, and 14% Other. The average age was 36 years (SD = 12.2; range: 19–71 years), 75% were female; and 70% had a college degree.
Reliable change and clinically significant improvement
Wampold et al (2001) conducted a meta-analysis of psychotherapy outcome studies and noted that the average improvement was reflected in an effect size (ES) of .80. Because a change of 1 SD corresponds to an ES of 1.0, and .80 is considered to be a large ES, Wise (2004) concludes that a change of 1 SD is a defensible indicator of clinically significant change.
Mean
Sample | Mean | Comments |
---|---|---|
Clinical | 24.7 | Based on a sample of 240 participants with mild to moderate levels of self-reported depressive symptoms. The racial/ethnic composition of the sample was: 51% non-Hispanic White; 28% non-Hispanic Black, 8% Hispanic, and 14% Other. The average age was 36 years (SD = 12.2; range: 19–71 years), 75% were female; and 70% had a college degree. |
Normative | 23.85 | A sample of 293 adults (40% male, 60% female) with an average age of 49.5 (SD = 6.7) who had never meditated before. |
Standard Deviation
Sample | Mean | Comments |
---|---|---|
Clinical | 7.11 | Based on a sample of 240 participants with mild to moderate levels of self-reported depressive symptoms. The racial/ethnic composition of the sample was: 51% non-Hispanic White; 28% non-Hispanic Black, 8% Hispanic, and 14% Other. The average age was 36 years (SD = 12.2; range: 19–71 years), 75% were female; and 70% had a college degree. |
Normative | 7.33 | A sample of 293 adults (40% male, 60% female) with an average age of 49.5 (SD = 6.7) who had never meditated before. |
Reliability
Value | Comments |
---|---|
0.91 | With a sample of 240 racially diverse participants (75% female, 70% university educated) with mild to moderate depressive symptoms the internal consistency reliability estimate was 0.91 (Shallcross et al., 2020). |
Description | Score Range | |
---|---|---|
Minimum | 8 | |
2 SD below normative mean | 11.43 | |
1 SD below normative mean | 18 | |
Normative mean | 24.57 | |
1 SD above normative mean | 31.14 | |
2 SD above normative mean | 37.71 | |
Maximum | 40 |
Severity ranges
Ranges are drawn from a clinical population, as Full-Scale scores were not calculate in a normative sample. Values are from a sample of 240 participants with mild to moderate levels of self-reported depressive symptoms. The racial/ethnic composition of the sample was: 51% non-Hispanic White; 28% non-Hispanic Black, 8% Hispanic, and 14% Other. The average age was 36 years (SD = 12.2; range: 19–71 years), 75% were female; and 70% had a college degree.
Reliable change and clinically significant improvement
Wampold et al (2001) conducted a meta-analysis of psychotherapy outcome studies and noted that the average improvement was reflected in an effect size (ES) of .80. Because a change of 1 SD corresponds to an ES of 1.0, and .80 is considered to be a large ES, Wise (2004) concludes that a change of 1 SD is a defensible indicator of clinically significant change.
Mean
Sample | Mean | Comments |
---|---|---|
Clinical | 23.7 | Based on a sample of 240 participants with mild to moderate levels of self-reported depressive symptoms. The racial/ethnic composition of the sample was: 51% non-Hispanic White; 28% non-Hispanic Black, 8% Hispanic, and 14% Other. The average age was 36 years (SD = 12.2; range: 19–71 years), 75% were female; and 70% had a college degree. |
Normative | 24.57 | A sample of 293 adults (40% male, 60% female) with an average age of 49.5 (SD = 6.7) who had never meditated before. |
Standard Deviation
Sample | Mean | Comments |
---|---|---|
Clinical | 5.81 | Based on a sample of 240 participants with mild to moderate levels of self-reported depressive symptoms. The racial/ethnic composition of the sample was: 51% non-Hispanic White; 28% non-Hispanic Black, 8% Hispanic, and 14% Other. The average age was 36 years (SD = 12.2; range: 19–71 years), 75% were female; and 70% had a college degree. |
Normative | 6.57 | A sample of 293 adults (40% male, 60% female) with an average age of 49.5 (SD = 6.7) who had never meditated before. |
Reliability
Value | Comments |
---|---|
0.9 | With a sample of 240 racially diverse participants (75% female, 70% university educated) with mild to moderate depressive symptoms the internal consistency reliability estimate was 0.90 (Shallcross et al., 2020). |
Description | Score Range | |
---|---|---|
Minimum | 8 | |
2 SD below normative mean | 10.51 | |
1 SD below normative mean | 17.57 | |
Normative mean | 24.63 | |
1 SD above normative mean | 31.69 | |
2 SD above normative mean | 38.75 | |
Maximum | 40 |
Severity ranges
Ranges are drawn from a clinical population, as Full-Scale scores were not calculate in a normative sample. Values are from a sample of 240 participants with mild to moderate levels of self-reported depressive symptoms. The racial/ethnic composition of the sample was: 51% non-Hispanic White; 28% non-Hispanic Black, 8% Hispanic, and 14% Other. The average age was 36 years (SD = 12.2; range: 19–71 years), 75% were female; and 70% had a college degree.
Reliable change and clinically significant improvement
Wampold et al (2001) conducted a meta-analysis of psychotherapy outcome studies and noted that the average improvement was reflected in an effect size (ES) of .80. Because a change of 1 SD corresponds to an ES of 1.0, and .80 is considered to be a large ES, Wise (2004) concludes that a change of 1 SD is a defensible indicator of clinically significant change.
Mean
Sample | Mean | Comments |
---|---|---|
Clinical | 27.19 | Based on a sample of 240 participants with mild to moderate levels of self-reported depressive symptoms. The racial/ethnic composition of the sample was: 51% non-Hispanic White; 28% non-Hispanic Black, 8% Hispanic, and 14% Other. The average age was 36 years (SD = 12.2; range: 19–71 years), 75% were female; and 70% had a college degree. |
Normative | 24.63 | A sample of 293 adults (40% male, 60% female) with an average age of 49.5 (SD = 6.7) who had never meditated before. |
Standard Deviation
Sample | Mean | Comments |
---|---|---|
Clinical | 6.94 | Based on a sample of 240 participants with mild to moderate levels of self-reported depressive symptoms. The racial/ethnic composition of the sample was: 51% non-Hispanic White; 28% non-Hispanic Black, 8% Hispanic, and 14% Other. The average age was 36 years (SD = 12.2; range: 19–71 years), 75% were female; and 70% had a college degree. |
Normative | 7.06 | A sample of 293 adults (40% male, 60% female) with an average age of 49.5 (SD = 6.7) who had never meditated before. |
Reliability
Value | Comments |
---|---|
0.93 | With a sample of 240 racially diverse participants (75% female, 70% university educated) with mild to moderate depressive symptoms, the internal consistency reliability estimate was 0.93 (Shallcross et al., 2020). |
Description | Score Range | |
---|---|---|
Minimum | 39 | |
2 SD below clinical mean | 80.28 | |
1 SD below clinical mean | 100.64 | |
Clinical mean | 121 | |
1 SD above clinical mean | 141.36 | |
2 SD above clinical mean | 161.72 | |
Maximum | 195 |
Severity ranges
Ranges are drawn from a clinical population, as Full-Scale scores were not calculate in a normative sample. Values are from a sample of 240 participants with mild to moderate levels of self-reported depressive symptoms. The racial/ethnic composition of the sample was: 51% non-Hispanic White; 28% non-Hispanic Black, 8% Hispanic, and 14% Other. The average age was 36 years (SD = 12.2; range: 19–71 years), 75% were female; and 70% had a college degree.
Reliable change and clinically significant improvement
Wampold et al (2001) conducted a meta-analysis of psychotherapy outcome studies and noted that the average improvement was reflected in an effect size (ES) of .80. Because a change of 1 SD corresponds to an ES of 1.0, and .80 is considered to be a large ES, Wise (2004) concludes that a change of 1 SD is a defensible indicator of clinically significant change.
Reliability
Value | Comments |
---|---|
0.82 | With a sample of 240 racially diverse participants (75% female, 70% university educated) with mild to moderate depressive symptoms internal consistency reliability estimates for the five facets (scales) were 0.82 or higher: Observing (8 items, alpha = 0.82), Describing (8 items, alpha = 0.93), Acting with Awareness (8 items, alpha = 0.90), Non-judging of inner experience (8 items, alpha = 0.91), and Non-reactivity to inner experience (7 items, alpha = 0.82) (Shallcross et al., 2020). |
Instrument developers
- Baer, R. A., Smith, G. T., Hopkins, J., Krietemeyer, J., & Toney, L. (2006). Using self-report assessment methods to explore facets of mindfulness. Assessment, 13(1), 27–45. https://doi.org/10.1177/1073191105283504
Refrences
* Baer, R. A., Smith, G. T., Hopkins, J., Krietemeyer, J., & Toney, L. (2006). Using self-report assessment methods to explore facets of mindfulness. Assessment, 13(1), 27–45. https://doi.org/10.1177/1073191105283504 * Baer, R. A., Smith, G. T., Lykins, E., Button, D., Krietemeyer, J., Sauer, S., Walsh, E., Duggan, D., & Williams, J. M. (2008). Construct validity of the five-facet mindfulness questionnaire in meditating and nonmeditating samples. Assessment, 15(3), 329–342. https://doi.org/10.1177/1073191107313003 * Karl, J.A., Fischer, R. (2020) Revisiting the five-facet structure of mindfulness. Measurement Instruments for the Social Sciences 2, 7. https://doi.org/10.1186/s42409-020-00014-3 * Shallcross, A., Lu, N. Y., & Hays, R. D. (2020). Evaluation of the Psychometric Properties of the Five Facet of Mindfulness Questionnaire. Journal of Psychopathology and Behavioral Assessment, 42(2), 271. https://doi.org/10.1007/s10862-019-09776-5 * Aguado, J., Luciano, J., Cebolla, A., Serrano-Blanco, A., Soler, J. & García-Campayo, J. (2015) Bifactor analysis and construct validity of the five facet mindfulness questionnaire (FFMQ) in non-clinical Spanish samples. Frontiers in Psychology, *6(*404). https://doi.org/110.3389/fpsyg.2015.00404 * Van Dam, N. T., Hobkirk, A. L., Danoff-Burg, S., & Earleywine, M. (2012). Mind Your Words: Positive and negative items create method effects on the five facet mindfulness questionnaire. Assessment, 19(2), 198-204. https://doi.org/10.1177/1073191112438743 * Bohlmeijer, E., Ten Klooster, P. M., Fledderus, M., Veehof, M., & * Baer, R. (2011). Psychometric properties of the five facet mindfulness questionnaire in depressed adults and development of a short form. Assessment, 18(3), 308-320.
Related Outcome Measures
CORE-10
Clinical Outcomes in Routine Evaluation 10
The Clinical Outcomes in Routine Evaluation 10 (CORE-10) is a 10-item assessment measure for common...
FFMQ
Five Facet Mindfulness Questionnaire
RAADS-R
Ritvo Autism Asperger Diagnostic Scale-Revised
The Ritvo Autism Asperger Diagnostic Scale-Revised (RAADS-R) is a 80-item self-report assessment me...
HAI-18
Health Anxiety Inventory-18
The items of the HAI-18 are intended to evaluate health anxiety regardless of physical health stat...
CESD-R
Center for Epidemiological Studies Depression Scale
The Center for Epidemiological Studies Depression Scale (CESD-R) is a self-report questionnaire des...
AQ-Child
Autism Spectrum Disorder in Children
The AQ-Child aims to assess traits of Autism Spectrum Disorder (ASD) in children with average intell...
AQ-Adolescent
Autism Spectrum Disorder in Adolescents
The AQ-Adol aims to assess traits of Autism Spectrum Disorder (ASD) in adolescents with average inte...
MDQ
Mood Disorder Questionnaire
The Mood Disorder Questionnaire (MDQ) was developed as a screening measure for bipolar disorder, us...
DUDIT
Drug Use Disorders Identification Test
The Drug Use Disorders Identification Test (DUDIT) is an 11-item self-report assessment measure whi...
ITQ
International Trauma Questionnaire
The ITQ is a self-report measure designed to assess the presence and functional impairment of postt...
IES-R
Impact of Event Scale-Revised
The Impact of Event Scale-Revised (IES-R) is a tool designed to gauge the presence and severity of s...
ACE-Q
The Adverse Childhood Experiences Questionnaire
The Adverse Childhood Experiences Questionnaire (ACE-Q) is a widely used tool for assessing childho...
MDRS-22
Male Depression Risk Scale
The Male Depression Risk Scale (MDRS) measures the risk of depression in men by assessing externali...
DES-II
Dissociative Experiences Scale-II
The DES-II is the most commonly used measure of dissociation. It measures various types of dissocia...
PSC-17
Pediatric Symptom Checklist-17
The PSC-17 is a screening tool designed to assess a child’s overall psychosocial functioning and i...
PCL-5
PTSD Checklist for DSM-5
The 20 symptoms of Post-Traumatic Stress Disorder, as outlined in the Diagnostic & Statistical Manua...
FAS
Fatigue Assessment Scale
The FAS full-scale assesses symptoms of physical and mental fatigue.
AQ
Autism Spectrum Quotient
The AQ aims to assess traits of Autism Spectrum Disorder (ASD) in adults and adolescents with averag...
PDSS-SR
Panic Disorder Severity Scale – Self-Report
The severity of Panic Disorder symptoms during the past week. Specifically, the instrument assesses...
SCAS-P
Spence Children’s Anxiety Scale – Parent
The SCAS-P measures anxiety symptoms in children in the general population through parent report. T...
PSEQ
Pain Self-Efficacy Questionnaire
The beliefs held by people experiencing chronic pain that they can carry out certain activities even...
PHQ-9
Patient Health Questionnaire 9-Item
Symptoms of Depression over the previous 2 weeks.
RIS
Regensburg Insomnia Scale
Psychological symptoms of insomnia assessing cognitive, emotional and behavioural aspects. The RIS m...
PSWQ
Penn State Worry Questionnaire
The PSWQ assesses pervasive and uncontrollable worry.
TSK-13
Tampa Scale of Kinesiophobia 13-Item
Kinesiophobia, defined as “an excessive, irrational, and debilitating fear of physical movement an...
GAD-7
Generalised Anxiety 7-Item
The symptoms of Generalized Anxiety Disorder, as outlined in the Diagnostic and Statistical Manual ...
CIA
Clinical Impairment Assessment Questionnaire
The severity of psychosocial impairment due to eating disorder pathology.
AUDIT
Alcohol Use Disorder Identification Test
The AUDIT identifies risky or harmful alcohol consumption, as well as alcohol dependence or abuse. ...
OCI-R
Obsessive-Compulsive Inventory – Revised
Symptom severity of Obsessive-Compulsive Disorder (OCD).The OCI-R contains 6 factors representing th...
AAI
Appearance Anxiety Inventory
Cognitive and behavioural symptoms of body image anxiety and body dysmorphic disorder (BDD). In part...
K10
Kessler Psychological Distress Scale
Non-specific psychological distress in the past 2 weeks.
SWLS
The Satisfaction With Life Scale
The Satisfaction With Life Scale (SWLS) examines the extent to which a person is satisfied with thei...
DASS-21
Depression Anxiety Stress Scales – 21-Item
Three self-report subscales assess the emotional states of depression, anxiety and stress.
CORE-OM
Clinical Outcomes in Routine Evaluation
The CORE-OM aims to capture the ‘core’ of client distress and provide a global index of distres...
BSL-23
Borderline Symptom List
The BSL-23 assesses 23 feelings and experiences that are typically reported by patients with Border...
ASRS
Adult ADHD Self-Report Scale
The ASRS aims to examine Attention Deficit Hyperactivity Disorder (ADHD) symptoms in adults consiste...
Severity ranges
Ranges are drawn from a clinical population, as Full-Scale scores were not calculate in a normative sample. Values are from a sample of 240 participants with mild to moderate levels of self-reported depressive symptoms. The racial/ethnic composition of the sample was: 51% non-Hispanic White; 28% non-Hispanic Black, 8% Hispanic, and 14% Other. The average age was 36 years (SD = 12.2; range: 19–71 years), 75% were female; and 70% had a college degree.
Reliable change and clinically significant improvement
Wampold et al (2001) conducted a meta-analysis of psychotherapy outcome studies and noted that the average improvement was reflected in an effect size (ES) of .80. Because a change of 1 SD corresponds to an ES of 1.0, and .80 is considered to be a large ES, Wise (2004) concludes that a change of 1 SD is a defensible indicator of clinically significant change.
Mean
Standard Deviation
Reliability